人民同泰：股票交易异常波动暨风险提示公告

Core Viewpoint - The stock price of Renmin Tongtai has experienced significant fluctuations, with a cumulative increase of 20% over two consecutive trading days, leading to a classification of abnormal trading behavior according to Shanghai Stock Exchange regulations [1] Group 1: Stock Performance - The stock price of Renmin Tongtai has seen a continuous increase, with a total rise of 46.43% from November 10 to November 13, 2025, while the Shanghai Composite Index only increased by 0.80% during the same period [1] - The stock price increase is significantly higher than the cumulative rise of 4.53% in the pharmaceutical commercial sector (Shenwan) [1] Group 2: Company and Market Conditions - The company conducted a self-examination and confirmed, after consulting with its controlling shareholder, that there are no undisclosed major events or important information [1] - The company’s main business has not undergone significant changes, indicating that the stock price surge may be driven by market sentiment and irrational speculation, posing a risk of rapid decline [1]